Non-alcoholic fatty liver disease: an emerging pathological spectrum

被引:69
|
作者
Zafrani, ES [1 ]
机构
[1] Hop Henri Mondor, Dept Pathol, F-94010 Creteil, France
关键词
non-alcoholic fatty liver disease; steatohepatitis; liver fibrosis; insulin resistance; mitochondrial dysfunction;
D O I
10.1007/s00428-003-0943-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The spectrum of pathological lesions observed in non-alcoholic fatty liver disease (NAFLD) is wide and strongly resembles that of alcohol-induced liver disease. It ranges from fatty liver to steatohepatitis, progressive fibrosis and cirrhosis. Hepatocellular carcinoma is a possible complication of NAFLD, but whether it is related to frequently associated metabolic disorders (e.g., overweight, diabetes) or to underlying cirrhosis is unclear. This disease is the result of a multi-factorial process in which insulin resistance seems to play a major role in the initial accumulation of fat in the liver, whereas multiple causes of mitochondrial dysfunction and oxidative stress can induce the secondary occurrence of necroinflammatory lesions and fibrosis. Genetic factors might explain why only some patients with simple steatosis will develop steatohepatitis and fibrosis. Due to the increasing prevalence of obesity in Western countries, NAFLD will possibly be a public health problem and the liver disease of the future.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 50 条
  • [1] Non-alcoholic fatty liver disease: an emerging pathological spectrum
    Elie Serge Zafrani
    [J]. Virchows Archiv, 2004, 444 : 3 - 12
  • [2] Emerging drugs for non-alcoholic fatty liver disease
    Federico, Alessandro
    Niosi, Marco
    Blanco, Camillo Del Vecchio
    Loguercio, Carmela
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (01) : 145 - 158
  • [3] Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2012, 111 (10) : 527 - 535
  • [4] Emerging Diagnostics and Therapeutics for Non-alcoholic Fatty Liver Disease
    Darbhanga, Jake
    Krulikowski, Kiarra
    Riskin, Suzanne I.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [5] Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease
    Patel, Samarth Siddharth
    Siddiqui, Mohammad Shadab
    [J]. DRUGS, 2019, 79 (01) : 75 - 84
  • [6] Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease
    Samarth Siddharth Patel
    Mohammad Shadab Siddiqui
    [J]. Drugs, 2019, 79 : 75 - 84
  • [7] THE PATHOLOGICAL PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE CORRELATES WITH GUT MICROBIOTA COMPOSITION IN MICE: FROM NON-ALCOHOLIC FATTY LIVER TO NON-ALCOHOLIC STEATOHEPATITIS
    Peng, J.
    Huang, F.
    Li, X.
    Chen, L.
    Feng, Q.
    Hu, Y.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S155 - S157
  • [8] Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis
    Sharma, Praveen
    Arora, Anil
    [J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [9] Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis
    Wong, Vincent Wai-Sun
    Singal, Ashwani K.
    [J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [10] Spectrum of histological features in non-alcoholic fatty liver disease
    Vasdev, Nandini
    Kakati, Anjali G.
    Saigal, Sanjiv
    Nayak, Nabeen C.
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2007, 20 (06): : 282 - 287